Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Nanotechnology
|
April 6, 2018
VSION as high field MRI T<sub>1</sub> contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography
T Vangijzegem, D Stanicki, S Boutry, et al.
Journal of Colloid and Interface Science
|
February 26, 2008
Enzymatically prepared n-alkyl esters of glucuronic acid: the effect of freeze-drying conditions and hydrophobic chain length on thermal behavior
C Blecker, S Danthine, M Pétré, et al.
Chemical Communications (Cambridge, England)
|
October 28, 2016
Following the stability of amphiphilic nanoaggregates by using intermolecular energy transfer
M Harris, H De Keersmaecker, L Vander Elst, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 29, 2001
Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study
G Le Duc, L Vander Elst, J M Colet, et al.
Investigative Radiology
|
September 1, 1988
The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development
R N Muller, L Vander Elst, P A Rinck, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2007
A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
G Yu, M Yamashita, K Aoshima, et al.
Contrast Media & Molecular Imaging
|
October 26, 2010
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death
K A Radermacher, S Boutry, S Laurent, et al.
NMR in Biomedicine
|
August 30, 2011
Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death
K A Radermacher, J Magat, C Bouzin, et al.
Blood
|
December 23, 1999
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
M Jacquemin, A Benhida, K Peerlinck, et al.
Nanotechnology
|
October 18, 2014
A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors
G Rigaux, V G Roullin, C Cadiou, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Nanotechnology
|
April 6, 2018
VSION as high field MRI T<sub>1</sub> contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography
T Vangijzegem, D Stanicki, S Boutry, et al.
Journal of Colloid and Interface Science
|
February 26, 2008
Enzymatically prepared n-alkyl esters of glucuronic acid: the effect of freeze-drying conditions and hydrophobic chain length on thermal behavior
C Blecker, S Danthine, M Pétré, et al.
Chemical Communications (Cambridge, England)
|
October 28, 2016
Following the stability of amphiphilic nanoaggregates by using intermolecular energy transfer
M Harris, H De Keersmaecker, L Vander Elst, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 29, 2001
Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study
G Le Duc, L Vander Elst, J M Colet, et al.
Investigative Radiology
|
September 1, 1988
The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development
R N Muller, L Vander Elst, P A Rinck, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2007
A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
G Yu, M Yamashita, K Aoshima, et al.
Contrast Media & Molecular Imaging
|
October 26, 2010
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death
K A Radermacher, S Boutry, S Laurent, et al.
NMR in Biomedicine
|
August 30, 2011
Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death
K A Radermacher, J Magat, C Bouzin, et al.
Blood
|
December 23, 1999
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
M Jacquemin, A Benhida, K Peerlinck, et al.
Nanotechnology
|
October 18, 2014
A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors
G Rigaux, V G Roullin, C Cadiou, et al.
Page
of 5